Immune checkpoint inhibitor-related myocarditis in patients with lung cancer
Abstract Background The clinical characteristics of immune checkpoint inhibitors (ICIs)-related myocarditis in lung cancer remains uncertain. The purpose of this study was to evaluate the incidence, clinical characteristics, risk factors, and prognosis of myocarditis in lung cancer patients treated...
Saved in:
| Main Authors: | Wenli Cao, Sen Han, Panpan Zhang, Lan Mi, Yang Wang, Jun Nie, Ling Dai, Weiheng Hu, Jie Zhang, Xiaoling Chen, Xiangjuan Ma, Guangming Tian, Jindi Han, Di Wu, Jieran Long, Ziran Zhang, Qianyun Hao, Jian Fang, Kai Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-13997-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early detection of myocarditis caused by immune checkpoint inhibitor therapy with nivolumab and ipilimumab for advanced recurrent renal cell carcinoma
by: Maki Todo, et al.
Published: (2025-02-01) -
Myocarditis and pericarditis after vaccination for COVID‐19
by: Blake Hudson, et al.
Published: (2021-08-01) -
Acute myocarditis according to age: Presentation, management and early outcomes
by: Clément Karsenty, et al.
Published: (2025-08-01) -
Prevalence of myocarditis, genetic cardiomyopathies and their combinations among patients of the Cardiology Hospital of the V.N. Vinogradov Faculty Therapeutic Clinic of the Sechenov University
by: D. V. Ruchkin, et al.
Published: (2022-08-01) -
Fulminant myocarditis associated with human rhinovirus A66 infection: a case report
by: Shuaibing Han, et al.
Published: (2024-10-01)